[Studies of the therapeutical effects and intolerance levels of morphazinamide in pulmonary tuberculosis].
D000995:Antitubercular Agents / Q000627:therapeutic use*; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*
D000995:Antitubercular Agents; D009025:Morpholines; D011719:Pyrazines
Estudio de los efectos terapeúticos y signos de intolerancia de la morfazinamida en la tuberculosis pulmonar.